4//SEC Filing
ARRAY BIOPHARMA INC 4
Accession 0001127602-14-026054
CIK 0001100412operating
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 5:01 PM ET
Size
5.6 KB
Accession
0001127602-14-026054
Insider Transaction Report
Form 4
Transactions
- Award
Restricted Stock Units
2014-08-18+25,655→ 25,655 totalExercise: $0.00Exp: 2018-08-18→ Common Stock (25,655 underlying)
Footnotes (2)
- [F1]Restricted Stock Units were awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock.
- [F2]The RSU's vest upon achievement of certain milestones relating to a program licensed by the Company to Novartis International Pharmaceutical Ltd., with one half vesting upon achievement of the first milestone relating to the return of commercialization rights for binimetinib to the Company that have been licensed to Novartis International Pharmaceutical Ltd. and one half vesting upon achievement of the second milestone on or prior to the fourth anniversary of the grant date, in each case subject to continued service with the Company as of each vesting date.
Documents
Issuer
ARRAY BIOPHARMA INC
CIK 0001100412
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001100412
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 5:01 PM ET
- Size
- 5.6 KB